Checkpoint-inhibition in ovarian cancer: rising star or just a dream?

The introduction of checkpoint inhibitors revolutionized immuno-oncology. The efficacy of traditional immunotherapeutics, like vaccines and immunostimulants was very limited due to persistent immune-escape strategies of cancer cells. Checkpoint inhibitors target these escape mechanisms and re-direct...

Descripción completa

Detalles Bibliográficos
Autores principales: Pietzner, Klaus, Nasser, Sara, Alavi, Sara, Darb-Esfahani, Silvia, Passler, Mona, Muallem, Mustafa Zelal, Sehouli, Jalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189441/
https://www.ncbi.nlm.nih.gov/pubmed/30207101
http://dx.doi.org/10.3802/jgo.2018.29.e93

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189441/
https://www.ncbi.nlm.nih.gov/pubmed/30207101
http://dx.doi.org/10.3802/jgo.2018.29.e93

Ejemplares similares